| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |